跳至主要内容
临床试验/IRCT20080901001159N20
IRCT20080901001159N20招募中2 期

Evaluation of the efficacy and safety of amniotic membrane seeded by allogenic skin cells on chronic wound of patients with dystrophic epidermolysis bullosa; phase II randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 years 至 20 years(—)
性别
All

入选标准

  • Patients with 2-20 years old
  • Dystrophic type of EB
  • Multiple skin wounds which are recurrent during 6 months ago

排除标准

  • Pregnancy or lactating
  • Arterial or venous defects in recipient site
  • Immune defficiency
  • Hemolytic anemia
  • Chronic malnutrition
  • Respiratory system defects
  • Local infection of recipient site
  • Cell transplantation of recipient site during last 1 year
  • HBV, HCV, and HIV infection
  • Any malignancy of recipient site

研究者

相似试验